Specific Mycobacterium tuberculosis T cell responses to RD1-selected peptides for the monitoring of anti-tuberculosis therapy

References

• World Health Organization. Global tuberculosis control—epidemiology, strategy, financing. WHO/HTM/TB/2009. 411. Geneva, Switzerland: WHO; 2009.
   Google Scholar
• Dominguez J, Latorre I, Altet N, Mateo L, De Souza-Galvão M, Ruiz-Manzano J, . IFN-gamma release assays to diagnose tuberculosis infection in the immunocompromised individual. Expert Rev Resp Med 2009;3:309–27.
   PubMedGoogle Scholar
• Dominguez J, Ruiz-Manzano J, De Souza-Galvao M, Latorre I, Mila C, Blanco S, . Comparison of two commercially available gamma interferon blood tests for immunodiagnosis of tuberculosis. Clin Vaccine Immunol 2008;15: 168–71.
   PubMedGoogle Scholar
• Ewer K, Deeks J, Alvarez L, Bryant G, Waller S, Andersen P, . Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak. Lancet 2003;361:1168–73.
   PubMed Web of Science ®Google Scholar
• Casas I, Latorre I, Esteve M, Ruiz-Manzano J, Rodriguez D, Prat C, . Evaluation of interferon-gamma release assays in the diagnosis of recent tuberculosis infection in health care workers. PLoS One 2009;4:e6686.
   Web of Science ®Google Scholar
• Lalvani A, Pathan AA, Durkan H, Wilkinson KA, Whelan A, Deeks JJ, . Enhanced contact tracing and spatial tracking of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Lancet 2001;357: 2017–21.
   PubMed Web of Science ®Google Scholar
• Latorre I, De Souza-Galvão M, Ruiz-Manzano J, Lacoma A, Prat C, Altet N, . Evaluating the non-tuberculous mycobacteria effect in the tuberculosis infection diagnosis. Eur Respir J 2010;35:338–42.
   PubMed Web of Science ®Google Scholar
• Altet-Gómez N, De Souza-Galvao M, Latorre I, Milá C, Jimenez MA, Solsona J, . Diagnosing TB infection in children: analysis of discordances using in vitro tests and tuberculin skin test. Eur Respir J 2011;37:1166–74.
   PubMed Web of Science ®Google Scholar
• Dominguez J, De Souza-Galvao M, Ruiz-Manzano J, Latorre I, Prat C, Lacoma A, . T-cell responses to the Mycobacterium tuberculosis-specific antigens in active tuberculosis patients at the beginning, during, and after antituberculosis treatment. Diagn Microbiol Infect Dis 2009; 63:43–51.
   PubMed Web of Science ®Google Scholar
• Lalvani A. Diagnosing tuberculosis infection in the 21st century: new tools to tackle an old enemy. Chest 2007;131: 1898–906.
   PubMed Web of Science ®Google Scholar
• Pai M, Menzies D. Interferon-gamma release assays: what is their role in the diagnosis of active tuberculosis? Clin Infect Dis 2007;44:74–7.
   PubMed Web of Science ®Google Scholar
• Latorre I, De Souza-Galvao M, Ruiz-Manzano J, Lacoma A, Prat C, Fuenzalida L, . Quantitative evaluation of T-cell response after specific antigen stimulation in active and latent tuberculosis infection in adults and children. Diagn Microbiol Infect Dis 2009;65:236–46.
   PubMed Web of Science ®Google Scholar
• Andersen P, Munk ME, Pollock JM, Doherty TM. Specific immune-based diagnosis of tuberculosis. Lancet 2000;356: 1099–104.
   PubMed Web of Science ®Google Scholar
• Brock I, Weldingh K, Leyten EM, Arend SM, Ravn P, Andersen P. Specific T-cell epitopes for immunoassay-based diagnosis of Mycobacterium tuberculosis infection. J Clin Microbiol 2004;42:2379–87.
   PubMed Web of Science ®Google Scholar
• Goletti D, Vincenti D, Carrara S, Butera O, Bizzoni F, Bernardini G, . Selected RD1 peptides for active tuberculosis diagnosis: comparison of a gamma interferon whole-blood enzyme-linked immunosorbent assay and an enzyme-linked immunospot assay. Clin Diagn Lab Immunol 2005;12:1311–6.
   PubMedGoogle Scholar
• Lalvani A. Counting antigen-specific T cells: a new approach for monitoring response to tuberculosis treatment? Clin Infect Dis 2004;38:757–9.
   PubMed Web of Science ®Google Scholar
• Pathan AA, Wilkinson KA, Klenerman P, McShane H, Davidson RN, Pasvol G, . Direct ex vivo analysis of antigen-specific IFN-gamma-secreting CD4 T cells in Mycobacterium tuberculosis-infected individuals: associations with clinical disease state and effect of treatment. J Immunol 2001;167:5217–25.
   PubMed Web of Science ®Google Scholar
• Lalvani A, Nagvenkar P, Udwadia Z, Pathan AA, Wilkinson KA, Shastri JS, . Enumeration of T cells specific for RD1-encoded antigens suggests a high prevalence of latent Mycobacterium tuberculosis infection in healthy urban Indians. J Infect Dis 2001;183:469–77.
   PubMed Web of Science ®Google Scholar
• Sauzullo I, Mengoni F, Lichtner M, Massetti AP, Rossi R, Iannetta M, . In vivo and in vitro effects of antituberculosis treatment on mycobacterial interferon-gamma T cell response. PLoS One 2009;4:e5187.
   PubMed Web of Science ®Google Scholar
• Ferrand RA, Bothamley GH, Whelan A, Dockrell HM. Interferon-gamma responses to ESAT-6 in tuberculosis patients early into and after anti-tuberculosis treatment. Int J Tuberc Lung Dis 2005;9:1034–9.
   PubMed Web of Science ®Google Scholar
• Ulrichs T, Anding R, Kaufmann SH, Munk ME. Numbers of IFN-gamma-producing cells against ESAT-6 increase in tuberculosis patients during chemotherapy. Int J Tuberc Lung Dis 2000;4:1181–3.
   PubMed Web of Science ®Google Scholar
• Al-Attiyah R, Mustafa AS, Abal AT, Madi NM, Andersen P. Restoration of mycobacterial antigen-induced proliferation and interferon-gamma responses in peripheral blood mononuclear cells of tuberculosis patients upon effective chemotherapy. FEMS Immunol Med Microbiol 2003;38:249–56.
   PubMedGoogle Scholar
• Vincenti D, Carrara S, De Mori P, Pucillo LP, Petrosillo N, Palmieri F, . Identification of early secretory antigen target-6 epitopes for the immunodiagnosis of active tuberculosis. Mol Med 2003;9:105–11.
   PubMed Web of Science ®Google Scholar
• Carrara S, Vincenti D, Petrosillo N, Amicosante M, Girardi E, Goletti D. Use of a T cell-based assay for monitoring efficacy of antituberculosis therapy. Clin Infect Dis 2004;38:754–6.
   PubMed Web of Science ®Google Scholar
• SEPAR (Sociedad Española de Patología Respiratoria). [Guidelines for tuberculosis prevention]. Arch Bronconeumol 2002;38:441–51.
   PubMed Web of Science ®Google Scholar
• Ruiz-Manzano J, Blanquer R, Calpe JL, Caminero JA, Cayla J, Dominguez JA, . [Diagnosis and treatment of tuberculosis]. Arch Bronconeumol 2008;44:551–66.
   PubMed Web of Science ®Google Scholar
• Goletti D, Stefania C, Butera O, Amicosante M, Ernst M, Sauzullo I, . Accuracy of immunodiagnostic tests for active tuberculosis using single and combined results: a multicenter TBNET-Study. PLoS One 2008;3:e3417.
   Web of Science ®Google Scholar
• Ewer K, Millington KA, Deeks JJ, Alvarez L, Bryant G, Lalvani A. Dynamic antigen-specific T-cell responses after point-source exposure to Mycobacterium tuberculosis. Am J Respir Crit Care Med 2006;174:831–9.
   PubMed Web of Science ®Google Scholar
• Goletti D, Carrara S, Vincenti D, Saltini C, Rizzi EB, Schinina V, . Accuracy of an immune diagnostic assay based on RD1 selected epitopes for active tuberculosis in a clinical setting: a pilot study. Clin Microbiol Infect 2006;12:544–50.
   PubMed Web of Science ®Google Scholar
• Sauzullo I, Mengoni F, Lichtner M, Rossi R, Massetti AP, Mastroianni CM, . QuantiFERON-TB Gold and selected region of difference 1 peptide-based assays for the detection of Mycobacterium tuberculosis infection in a cohort of patients enrolled with suspected tuberculosis. Diagn Microbiol Infect Dis 2008;62:395–401.
   PubMed Web of Science ®Google Scholar
• Goletti D, Carrara S, Mayanja-Kizza H, Baseke J, Mugerwa MA, Girardi E, . Response to M. tuberculosis selected RD1 peptides in Ugandan HIV-infected patients with smear positive pulmonary tuberculosis: a pilot study. BMC Infect Dis 2008;8:11.
   PubMed Web of Science ®Google Scholar
• Millington KA, Innes JA, Hackforth S, Hinks TS, Deeks JJ, Dosanjh DP, . Dynamic relationship between IFN-gamma and IL-2 profile of Mycobacterium tuberculosis-specific T cells and antigen load. J Immunol 2007;178: 5217–26.
   PubMed Web of Science ®Google Scholar
• Ruhwald M, Bodmer T, Maier C, Jepsen M, Haaland MB, Eugen-Olsen J, . Evaluating the potential of IP-10 and MCP-2 as biomarkers for the diagnosis of tuberculosis. Eur Respir J 2008;32:1607–15.
   PubMed Web of Science ®Google Scholar
• Azzurri A, Sow OY, Amedei A, Bah B, Diallo S, Peri G, . IFN-gamma-inducible protein 10 and pentraxin 3 plasma levels are tools for monitoring inflammation and disease activity in Mycobacterium tuberculosis infection. Microbes Infect 2005;7:1–8.
   PubMed Web of Science ®Google Scholar
• Ruhwald M, Dominguez J, Latorre I, Losi M, Richeldi L, Pasticci MB, . A multicentre evaluation of the accuracy and performance of IP-10 for the diagnosis of infection with M. tuberculosis. Tuberculosis (Edinb) 2011;91:260–7.
   PubMed Web of Science ®Google Scholar
• Goletti D, Raja A, Ahamed Kabeer BS, Rodrigues C, Sodha A, Butera O, . IFN-gamma, but not IP-10, MCP-2 or IL-2 response to RD1 selected peptides associates to active tuberculosis. J Infect 2010;61:133–43.
   PubMed Web of Science ®Google Scholar
• Syed Ahamed Kabeer B, Raja A, Raman B, Thangaraj S, Leportier M, Ippolito G, . IP-10 response to RD1 antigens might be a useful biomarker for monitoring tuberculosis therapy. BMC Infect Dis 2011;11:135.
   PubMed Web of Science ®Google Scholar
• Goletti D, Parracino MP, Butera O, Bizzoni F, Casetti R, Dainotto D, . Isoniazid prophylaxis differently modulates T-cell responses to RD1-epitopes in contacts recently exposed to Mycobacterium tuberculosis: a pilot study. Respir Res 2007;8:5.
   PubMed Web of Science ®Google Scholar